Otsu M, Katamine S, Uno M, Yamaki M, Ono Y, Klein G, Sasaki M S, Yaoita Y, Honjo T
Mol Cell Biol. 1987 Feb;7(2):708-17. doi: 10.1128/mcb.7.2.708-717.1987.
An in vitro culture of FLEB14 cells, an Epstein-Barr virus-transformed B cell precursor containing the germ line immunoglobulin genes, gave rise to a uniclonally expanded variant, FLEB14 delta 3, which was rearranged at the immunoglobulin heavy-chain gene locus. Cytogenetic analysis showed that FLEB14 delta 3 had a novel reciprocal translocation, t(6;14)(q15;q32). Molecular cloning of the rearranged DNA fragments and determination of their nucleotide sequence revealed that the recombination event was reciprocal, imprecise, and nonhomologous and took place in the S mu region, like those found in Burkitt's lymphoma cells. We propose a molecular model to explain this genetic event which may be relevant to class switch recombination. The translocated sequence of chromosome 6 did not contain any known oncogenes, although the sequence is conserved among mammals. FLEB14 delta 3 did not show tumorigenicity.
FLEB14细胞是一种含有种系免疫球蛋白基因的爱泼斯坦-巴尔病毒转化的B细胞前体,其体外培养产生了一个单克隆扩增变体FLEB14 delta 3,该变体在免疫球蛋白重链基因位点发生了重排。细胞遗传学分析表明,FLEB14 delta 3有一个新的相互易位,即t(6;14)(q15;q32)。对重排的DNA片段进行分子克隆并测定其核苷酸序列,结果显示重组事件是相互的、不精确的且非同源的,并且发生在Sμ区域,就像在伯基特淋巴瘤细胞中发现的那样。我们提出了一个分子模型来解释这一可能与类别转换重组相关的遗传事件。6号染色体的易位序列不包含任何已知的癌基因,尽管该序列在哺乳动物中是保守的。FLEB14 delta 3没有表现出致瘤性。